Dermatologia e pesquisa científica: análise das publicações em hospital de ensino no sul do Brasil

Introdução: a Dermatologia destaca-se entre as especialidades médicas por seu pioneirismo na descoberta e caracterização de afecções da pele, tornando-se proeminente a compreensão da conjuntura da produção científica na especialidade. Objetivo: analisar o perfil das publicações científicas do Serviço de Dermatologia da Santa Casa de Porto Alegre / Universidade Federal de Ciências da Saúde de Porto Alegre. Método: estudo transversal e descritivo realizado a partir da análise das publicações do Serviço de Dermatologia, no período de janeiro de 2019 a dezembro de 2020. Resultados: a partir do levantamento de dados, foram identificadas 54 publicações no período, constituídas 81,5% (n = 44) por artigos e 18,5% (n = 10) por capítulos de livro. A maioria dos artigos foram ‘relatos de casos’ (56,8%; n = 25). Cerca de 46,3% das publicações contaram com a participação de residentes e/ou especializandos, principalmente no 3º ano dos programas. Conclusão: a análise das publicações científicas revelou predomínio de artigos em periódicos, principalmente em veículos nacionais, com expressiva participação de especializandos. O desenvolvimento científico da Dermatologia pressupõe a valorização das atividades de pesquisa no âmbito dos programas de especialização e residência, com potencial de contribuição para a melhoria dos serviços de saúde e produtividade acadêmica.Background: Dermatology stands out among the medical specialties for its pioneering role in the discovery and characterization of skin conditions, making the understanding of the conjuncture of scientific production in the specialty prominent. Objective: the study aimed to analyze the profile of scientific publications of the Dermatology Service of Santa Casa of Porto Alegre / Federal University of Health Sciences of Porto Alegre. Method: this cross-sectional and descriptive study was conducted from the analysis of publications of the Dermatology Service, from January 2019 to December 2020. Results: from the data collection, 54 publications were identified in the analyzed period, consisting of 81.5% (n = 44) of articles and 18.5% (n = 10) of book chapters. Most articles were 'case reports' (56.8%; n = 25). About 46.3% of the publications had the participation of residents and/or trainees, mainly in the 3rd year of the programs. Conclusion: the analysis of scientific publications revealed a predominance of articles in journals, mainly in national vehicles, with a significant participation of students. The scientific development of Dermatology presupposes the valorization of research activities within the scope of specialization and residency programs, with the potential to contribute to the improvement of health services and academic productivity

Dermatologia e pesquisa científica: análise das publicações em hospital de ensino no sul do Brasil

Introdução: a Dermatologia destaca-se entre as especialidades médicas por seu pioneirismo na descoberta e caracterização de afecções da pele, tornando-se proeminente a compreensão da conjuntura da produção científica na especialidade. Objetivo: analisar o perfil das publicações científicas do Serviço de Dermatologia da Santa Casa de Porto Alegre / Universidade Federal de Ciências da Saúde de Porto Alegre. Método: estudo transversal e descritivo realizado a partir da análise das publicações do Serviço de Dermatologia, no período de janeiro de 2019 a dezembro de 2020. Resultados: a partir do levantamento de dados, foram identificadas 54 publicações no período, constituídas 81,5% (n = 44) por artigos e 18,5% (n = 10) por capítulos de livro. A maioria dos artigos foram ‘relatos de casos’ (56,8%; n = 25). Cerca de 46,3% das publicações contaram com a participação de residentes e/ou especializandos, principalmente no 3º ano dos programas. Conclusão: a análise das publicações científicas revelou predomínio de artigos em periódicos, principalmente em veículos nacionais, com expressiva participação de especializandos. O desenvolvimento científico da Dermatologia pressupõe a valorização das atividades de pesquisa no âmbito dos programas de especialização e residência, com potencial de contribuição para a melhoria dos serviços de saúde e produtividade acadêmica

Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger?

Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-CoV-2. However, vaccines have produced adverse effects in some patients. We report the case of a 44-year-old man who developed a pruritic papulosquamous rash on the trunk with a characteristic pattern known as Christmas tree after receiving the first dose of the Oxford- AstraZeneca COVID-19 vaccine, similar to pityriasis rosea (PR). He had no previous symptoms of viral infection and tested negative for neutralizing antibodies (enzyme immunoassay) against COVID-19. There are few reports in the literature about the relationship between the onset of cutaneous adverse reactions and the Oxford-AstraZeneca vaccine, therefore, the disseminationof this case is of paramount importance.Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-CoV-2. However, vaccines have produced adverse effects in some patients. We report the case of a 44-year-old man who developed a pruritic papulosquamous rash on the trunk with a characteristic pattern known as Christmas tree after receiving the first dose of the Oxford- AstraZeneca COVID-19 vaccine, similar to pityriasis rosea (PR). He had no previous symptoms of viral infection and tested negative for neutralizing antibodies (enzyme immunoassay) against COVID-19. There are few reports in the literature about the relationship between the onset of cutaneous adverse reactions and the Oxford-AstraZeneca vaccine, therefore, the disseminationof this case is of paramount importance

Multiple cutaneous telangiectasias after the use of trastuzumab: a case report

We aim to report a particular case of cutaneous telangiectasias on the arms after immunotherapy with trastuzumab plus paclitaxel to treat breast cancer. New oncology therapies reflect a major advance in cancer treatment. They greatly increase survival; however, they still cause certain adverse cutaneous events that should be taken into account for their proper management.We aim to report a particular case of cutaneous telangiectasias on the arms after immunotherapy with trastuzumab plus paclitaxel to treat breast cancer. New oncology therapies reflect a major advance in cancer treatment. They greatly increase survival; however, they still cause certain adverse cutaneous events that should be taken into account for their proper management

Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger?

Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-CoV-2. However, vaccines have produced adverse effects in some patients. We report the case of a 44-year-old man who developed a pruritic papulosquamous rash on the trunk with a characteristic pattern known as Christmas tree after receiving the first dose of the Oxford- AstraZeneca COVID-19 vaccine, similar to pityriasis rosea (PR). He had no previous symptoms of viral infection and tested negative for neutralizing antibodies (enzyme immunoassay) against COVID-19. There are few reports in the literature about the relationship between the onset of cutaneous adverse reactions and the Oxford-AstraZeneca vaccine, therefore, the disseminationof this case is of paramount importance.Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-CoV-2. However, vaccines have produced adverse effects in some patients. We report the case of a 44-year-old man who developed a pruritic papulosquamous rash on the trunk with a characteristic pattern known as Christmas tree after receiving the first dose of the Oxford- AstraZeneca COVID-19 vaccine, similar to pityriasis rosea (PR). He had no previous symptoms of viral infection and tested negative for neutralizing antibodies (enzyme immunoassay) against COVID-19. There are few reports in the literature about the relationship between the onset of cutaneous adverse reactions and the Oxford-AstraZeneca vaccine, therefore, the disseminationof this case is of paramount importance

Multiple cutaneous telangiectasias after the use of trastuzumab: a case report

We aim to report a particular case of cutaneous telangiectasias on the arms after immunotherapy with trastuzumab plus paclitaxel to treat breast cancer. New oncology therapies reflect a major advance in cancer treatment. They greatly increase survival; however, they still cause certain adverse cutaneous events that should be taken into account for their proper management.We aim to report a particular case of cutaneous telangiectasias on the arms after immunotherapy with trastuzumab plus paclitaxel to treat breast cancer. New oncology therapies reflect a major advance in cancer treatment. They greatly increase survival; however, they still cause certain adverse cutaneous events that should be taken into account for their proper management